Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,307.20 -80.41 -0.52%
S&P 500 1,655.35 -13.81 -0.83%
Nasdaq 3,463.30 -38.82 -1.11%
Ticker Volume Price Price Delta
STOXX 50 2,835.01 +13.36 0.47%
FTSE 100 6,840.27 +36.40 0.53%
DAX 8,530.89 +58.69 0.69%
Ticker Volume Price Price Delta
Nikkei 15,897.60 +270.34 1.73%
Hang Seng 23,105.40 -155.66 -0.67%
S&P/ASX 200 5,094.10 -71.27 -1.38%
  • Exchange: London
  • Sector: Consumer, Non-cyclical
  • Industry: Pharmaceuticals
  • Sub-Industry: Medical-Drugs

GlaxoSmithKline PLC

+ Add to Watchlist

GSK:LN

1,773.000 GBp 31.000 1.78%

As of 11:35:04 ET on 05/22/2013.

Company Profile for GlaxoSmithKline PLC (GSK)

GlaxoSmithKline PLC is a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart & circulatory disease, and cancer.

Contact Information

GlaxoSmithKline PLC

980 Great West Road
Brentford, TW8 9GS
United Kingdom
Phone: 44-20-8047-5000
Fax: 44-20-8966-8330

Key Executives for GlaxoSmithKline PLC (GSK)

Andrew WittyChief Executive OfficerSimon P DingemansChief Financial Officer
David RedfernChief Strategy OfficerMoncef SlaouiChairman:R&D & Vaccines
Roger ConnorPresident:Global ManufacturingDeirdre P ConnellyPresident:North America
Shah Abbas HussainPresident:Europe & EmapPatrick VallancePresident:Pharmaceuticals R&D
Emma WalmsleyPresident:Consumer HealthcareDaniel E Troy "Dan"Senior VP/General Counsel
Simon Michael BicknellSenior VP:Governance & EthicsClaire ThomasSenior VP:Human Resources
Bill LouvSenior VP:Core Bus SvcsPhilip Thomson "Phil"Senior VP:Global Communication
Victoria Anne WhyteSecretaryMarc DunoyerHead:Rare Diseases Unit
Sally FergusonInvestor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil